about
Cyclic thrombocytopenia associated with marked rebound thrombocytosis and fluctuating levels of endogenous thrombopoietin and reticulated platelets: a case report.Flow cytometry demonstrates differences in platelet reactivity and microparticle formation in subjects with thrombocytopenia or thrombocytosis due to primary haematological disorders.Morphological changes in vascular and circulating blood cells following exposure to detergent sclerosants.Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro.Basic physiochemical and rheological properties of detergent sclerosants.Flow Cytometry Protocols for Assessment of Platelet Function in Whole Blood.Generation and characterization of mice with null mutation of the chloride intracellular channel 1 gene.Control of glycolysis in mature boar spermatozoa: effect of pH in vitro.Sclerosant foam structure and stability is strongly influenced by liquid air fraction.Nucleus pulposus cellular longevity by telomerase gene therapy.Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT.In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.Longitudinal changes in hemostatic parameters and reduced pulsatility contribute to non-surgical bleeding in patients with centrifugal continuous-flow left ventricular assist devices.Telangiectatic Matting is Associated with Hypersensitivity and a Bleeding Tendency.The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.Detergent Sclerosants Stimulate Leukocyte Apoptosis and Oncosis.A convenient source of carbon dioxide for sclerosant foams.Generation of sclerosant foams by mechanical methods increases the foam temperature.Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response.Detergent sclerosants at sub-lytic concentrations induce endothelial cell apoptosis through a caspase dependent pathway.Effects of antiplatelet therapy on platelet extracellular vesicle release and procoagulant activity in health and in cardiovascular disease.Generation and characterization of mice with null mutation of the chloride intracellular channel 1 genePlatelet activation in acute pulmonary embolismLow concentration detergent sclerosants induce platelet activation but inhibit aggregation due to suppression of GPIIb/IIIa activation in vitroInfusion of foam sclerosants results in a distance-dependent procoagulant activity, haemoconcentration and elevation of D-dimer levelsFoam sclerosants are more stable at lower temperaturesDetergent sclerosants are deactivated and consumed by circulating blood cellsLow-concentration detergent sclerosants stimulate white blood cells and release proinflammatory and proangiogenic cytokines in vitroDeep vein sclerosis following sclerotherapy: Ultrasonic and d-dimer criteriaSirolimus and propranolol inhibit endothelial proliferation while detergent sclerosants induce endothelial activation, microparticle release and apoptosis in vitroTwo layers of graduated compression stockings can reduce healthy saphenous vein diameters in the standing positionCirculating blood cells influence the fibrinolytic capacity of clots generated in the presence of detergent sclerosantsXVIII UIP World Congress - Melbourne, February 3-8, 2018. ABSTRACTSCyanoacrylate closure for peripheral veins: Consensus document of the Australasian College of PhlebologyAngioscopy: Direct visualization of chronic venous occlusion, May-Thurner syndrome, and other applications in phlebology
P50
Q33397874-D06F0824-23A6-48C5-825C-473795BB80E5Q33410737-C158EBEC-6312-4983-8915-A987E4CB8672Q35563761-2B36F663-7130-4BFF-BDC5-35C138BF795BQ39122689-170FD08E-CB92-4AE4-ABC7-50AEEFFCD865Q39994053-3ADCF8B7-2F9B-4DC0-B867-CCE9A8359DC5Q40180243-1A0FD4C7-8E62-4518-8347-838E90717B71Q42513624-19BCA7D1-4989-47E3-99CD-3E020057D445Q43202347-77784FD8-D543-4A11-A47F-2CB0FF78DD66Q45013567-D65280AB-2562-4FCA-9E73-4581248ED0C3Q45414203-571A5AA5-2606-48B9-B0B4-8A725DD0937BQ45867992-910A234A-67DE-4649-9348-411BED66226DQ45932171-B6016ED5-DD86-431D-AFE1-F5B334012E07Q46963456-4C031721-3476-4000-A9A1-D841F529CC14Q48846793-98838CDC-C020-4069-BB23-AA04D64BF755Q50154948-34137BE2-6ADF-4C60-8E9C-96DC79E7E708Q50191909-DB5C92B0-CF0D-4A70-9255-24853C3B0D0DQ50202909-263E1BE6-1086-4A4F-BF19-7963F694FFC2Q51089255-A295F86C-6C76-4A28-AD55-70DB7863E2CBQ51139085-FF243E0B-0BBF-493F-8CBF-6D6EF6576E96Q52641024-3CC9CF14-0996-4670-A52F-7B7C8D7DBC98Q53094475-96CC9B7D-317D-4E0B-BE38-927CBBD16F10Q53598292-949815C2-7136-47CC-8D34-9FE10CB45B9BQ57831567-5D643FA3-CE56-48D4-82E1-C87FB1A7175CQ79983029-EE627F75-9BC4-472B-B6F2-B25D3CC9C937Q83982629-BC0E5C3C-33A1-4245-8042-2B1598EC649EQ85196572-AFDD57E5-44AD-4E0C-823D-EBC90AE32220Q86045085-04043A19-E903-4140-BAE7-C98D9EB98D1FQ86747668-05B620B9-29FD-41AF-B2AE-095F4DC4B3EDQ87493603-38293AEB-C7CF-41B7-BDCD-03F05BC748B9Q90065787-DB104004-4A1A-4776-8508-62248B219440Q90681845-6D097F0D-3B58-42F6-836E-31500ED37863Q91439709-8B91D8AF-2D1F-4E2B-A3F0-A096260157ECQ92029164-06E8278C-8CC0-455C-A0FB-8DEC8F36BAD2Q92201212-1FB93175-8AA8-42AB-A956-B5F5F9F5F032Q92332320-0E7C90DE-1529-4136-9285-35E5B6A95013Q92830150-19EF136B-FDC9-4DE3-92E5-DC538A58AD10
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David E. Connor
@ast
David E. Connor
@en
David E. Connor
@es
David E. Connor
@sl
type
label
David E. Connor
@ast
David E. Connor
@en
David E. Connor
@es
David E. Connor
@sl
prefLabel
David E. Connor
@ast
David E. Connor
@en
David E. Connor
@es
David E. Connor
@sl
P1053
B-8730-2011
P106
P1153
8602523200
P21
P31
P3829
P496
0000-0001-9602-7213